Government Accountability Office says more oversight needed on direct-to-consumer pharmaceuticals advertising
A recent Government Accountability Office report says that more FDA oversight is needed with respect to direct-to-consumer advertising by the pharmaceutical industry. Drug company spending on direct-to-consumer advertising increased twice as fast from 1997 through 2005 as spending on promotion to physicians or research and development. Examples of direct-to-consumer advertising are advertisements on television or in magazines. The Government Accountability Office says that more oversight is necessary to protect consumers from false or misleading advertising.
For the full report.
Bookmark: 
